levofloksacin lek 250 mg filmsko obložene tablete
lek d.d. - levofloksacin - filmsko obložena tableta - levofloksacin 250 mg / 1 tableta - levofloksacin
levoxa 250 mg filmsko obložene tablete
actavis group ptc ehf. - levofloksacin - filmsko obložena tableta - levofloksacin 250 mg / 1 tableta - levofloksacin
ciprofloksacin infomed fluids 2 mg/ml raztopina za infundiranje
infomed fluids srl - ciprofloksacin - raztopina za infundiranje - ciprofloksacin 2 mg / 1 ml - ciprofloksacin
ciprofloksacin infomed fluids 2 mg/ml raztopina za infundiranje
infomed fluids srl - ciprofloksacin - raztopina za infundiranje - ciprofloksacin 2 mg / 1 ml - ciprofloksacin
ciprofloksacin infomed fluids 2 mg/ml raztopina za infundiranjev
infomed fluids srl - ciprofloksacin - raztopina za infundiranje - ciprofloksacin 2 mg / 1 ml - ciprofloksacin
primotren 40 mg/200 mg v 5 ml peroralna suspenzija
lek d.d. - sulfametoksazol; trimetoprim - peroralna suspenzija - sulfametoksazol 200 mg / 5 ml trimetoprim40 mg / 5 ml; trimetoprim 40 mg / 5 ml - sulfametoksazol in trimetoprim
ciprofloksacin infomed fluids 2 mg/ml raztopina za infundiranje
infomed fluids srl - ciprofloksacin - raztopina za infundiranje - ciprofloksacin 2 mg / 1 ml - ciprofloksacin
tavanic 250 mg filmsko obložene tablete
sanofi-aventis d.o.o. - levofloksacin - filmsko obložena tableta - levofloksacin 250 mg / 1 tableta - levofloksacin
calquence
astrazeneca ab - acalabrutinib - levkemija, limfocitna, kronična, b-celica - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.
ospen 750 000 i.e./5 ml peroralna suspenzija
sandoz gmbh - fenoksimetilpenicilin - peroralna suspenzija - fenoksimetilpenicilin 507,7 mg / 5 ml - benzatinijev fenoksimetilpenicilinat